InnovAge (INNV) vs GeneDx (WGS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
InnovAge (INNV) has outperformed GeneDx (WGS) over the past year, gaining 75.2% versus a loss of 44.8%. Over five years, INNV leads with a +42.2% price change compared with -73.7% for WGS. GeneDx is the larger company by market cap ($2.02 billion vs $1.24 billion), about 1.6 times the size.
On valuation, InnovAge trades at a lower forward P/E (18.2x vs 56.5x for GeneDx).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INNV | WGS |
|---|---|---|
| Share price | $9.11 | $67.73 |
| Market cap | $1.24B | $2.02B |
| 1-day change | -0.22% | -1.17% |
| YTD return | +75.92% | -47.92% |
| 1-year return | +75.24% | -44.80% |
| 5-year return | +42.21% | -73.65% |
| Forward P/E | 18.22 | 56.51 |
| EPS (TTM) | $-0.02 | $-3.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.64 | $170.87 |
| 52-week low | $3.94 | $32.21 |
| Distance from 52-week high | -27.93% | -60.36% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +31.72% | +38.05% |
| Average volume | 440.40K | 728.47K |
| Shares outstanding | 136.45M | 29.82M |
| Employees | 2,500 | 1,300 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- INNV has outperformed WGS by 120.0 percentage points over the past year.
About InnovAge
INNV stock →InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors.
Health Care · Medical/Nursing Services · 2,500 employees
About GeneDx
WGS stock →GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Health Care · Medical/Nursing Services · 1,300 employees
INNV vs WGS FAQ
Which is bigger, InnovAge or GeneDx?
GeneDx (WGS) is larger, with a market capitalization of $2.02B compared with $1.24B for InnovAge (INNV).
Which stock has performed better over the past year, INNV or WGS?
INNV returned +75.24% over the past 12 months, compared with -44.80% for WGS (price return, excluding dividends). Past performance does not predict future results.
Are InnovAge and GeneDx in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.